
Novo Nordisk
OrganizationHeard in 138 episodes across 56 shows since Oct 2025
Novo Nordisk A/S is a Danish multinational pharmaceutical and global healthcare company headquartered in Bagsværd, Denmark. It develops, manufactures, and markets medicines and related products for serious chronic diseases, especially diabetes and obesity, including insulin and GLP-1 treatments such as Wegovy; the podcast references concern its medicines, research, manufacturing standards, partnerships, and public-company performance.
Episodes
This week
Expert statements
Share of the conversation
Mentions of Novo Nordisk per 1,000 mentions of anything, 7-day rolling, across the podcasts PodLume Trends follows.
Show the data
| Day | Share (7-day) | Mentions |
|---|---|---|
| Oct 14 | 0.05‰ | 2 |
| Oct 15 | 0.06‰ | 1 |
| Oct 16 | 0.08‰ | 2 |
| Oct 18 | 0.08‰ | 2 |
| Oct 19 | 0.09‰ | 2 |
| Oct 20 | 0.12‰ | 5 |
| Oct 21 | 0.11‰ | 1 |
| Oct 22 | 0.11‰ | 1 |
| Oct 23 | 0.12‰ | 4 |
| Oct 27 | 0.06‰ | 1 |
| Oct 28 | 0.06‰ | 1 |
| Oct 29 | 0.08‰ | 3 |
| Oct 30 | 0.05‰ | 1 |
| Oct 31 | 0.06‰ | 1 |
| Nov 1 | 0.10‰ | 5 |
| Nov 2 | 0.14‰ | 5 |
| Nov 3 | 0.15‰ | 1 |
| Nov 4 | 0.17‰ | 5 |
| Nov 5 | 0.16‰ | 1 |
| Nov 6 | 0.17‰ | 3 |
| Nov 8 | 0.14‰ | 2 |
| Nov 9 | 0.11‰ | 2 |
| Nov 10 | 0.13‰ | 3 |
| Nov 11 | 0.10‰ | 1 |
| Nov 13 | 0.09‰ | 3 |
| Nov 16 | 0.08‰ | 3 |
| Nov 17 | 0.07‰ | 2 |
| Nov 18 | 0.09‰ | 3 |
| Nov 19 | 0.10‰ | 1 |
| Nov 20 | 0.09‰ | 2 |
Email alert
Email me when Novo Nordisk comes up on a podcast
One email a week at most, with the new episodes that mention Novo Nordisk. Free, no account needed, unsubscribe in one click.
What experts have said about Novo Nordisk
43 statements · 22 positive · 18 negative · 1 mixed · 2 neutral
Novo Nordisk needs a stronger pipeline to advance its stock valuation.
“it's got to be pipeline oriented, I think, to get the stock to the next level.”
Open the episode · Market’s Post-Election Surge… And Prognosis For Pharma, Health Care After Midterms 11/4/26Listen at 33:35
- Hari RamachandraNegativeNov 1, 2026· The Investor's Podcast (We Study Billionaires) - The Investor’s Podcast Network
Novo Nordisk trades roughly 12 times forward earnings after falling 40% from its 52-week high.
“that stock is down 40%. And from its 52-week high, and it's trading roughly around 12 times forward earnings.”
Open the episode · TIP857: S&P Global, Novo, Deckers Brands w/ Stig Brodersen, Tobias Carlisle, & Hari RamachandraListen at 3:26
- Hari RamachandraPositiveNov 1, 2026· The Investor's Podcast (We Study Billionaires) - The Investor’s Podcast Network
Novo Nordisk is a century-old, high-quality business.
“it's a company that's 100 plus year old, great business.”
Open the episode · TIP857: S&P Global, Novo, Deckers Brands w/ Stig Brodersen, Tobias Carlisle, & Hari RamachandraListen at 4:12
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Episodes
138 episodes featuring Novo Nordisk, newest first
- Nov 20, 2026
Blockbuster games expose the risks behind tech-led growthThe Contrarians with Adam and AdirNov 20, 2026 - Nov 19, 2026
AI turns infrastructure into America’s next strategic contestSourceryNov 19, 2026 - Nov 18, 2026
Nvidia rally fades as Target and cybersecurity stocks stand outStock Market Today With IBDNov 18, 2026 - Nov 18, 2026
Gold falters as Anthropic tests IPO appetiteEquity Mates Investing PodcastNov 18, 2026 - Nov 18, 2026
Coinbase bets its future on AI agents and open financeDavid SenraNov 18, 2026 - Nov 17, 2026
FAA probes network failure as AI markets resetWSJ What’s NewsNov 17, 2026